News | Cath Lab | May 05, 2016

SCAI Publishes Updated Cath Lab Best Practices Guidelines

Document includes pre-, intra- and post-procedure recommendations

SCAI, cath lab, best practices, guidelines, 2016

May 5, 2016 — The Society for Cardiovascular Angiography and Interventions (SCAI) published an update to its 2012 paper outlining best practices in the cardiac catheterization laboratory (CCL), or cath lab. The paper, “SCAI Expert Consensus Statement: 2016 Best Practices in the Cardiac Catheterization Laboratory,” was published online in Catheterization and Cardiovascular Interventions, SCAI’s official journal.

The document provides cath labs around the country with a set of agreed-upon recommended guidelines developed by expert practicing interventional cardiologists to ensure the highest quality of care and ultimately better patient outcomes, as well as improved patient and physician satisfaction. The paper includes pre-, intra-, and post-procedure recommendations.

“SCAI created the Best Practices Guidelines in 2012 because there had been no process standardization in cath labs and labs had been working under only local regulation and policy,” said Srihari S. Naidu, M.D., FACC, FSCAI, FAHA, associate professor of medicine at the SUNY Stony Brook School of Medicine, director of the cardiac catheterization laboratory at Winthrop University Hospital and the paper’s lead author. “There is a tremendous appetite among interventional cardiologists for a comprehensive document outlining the details on how a cardiac cath lab should operate.”

The document includes:

  • An updated pre-procedure checklist for cardiac catheterization that provides a nurse, technician, APP, physician extender or physician with a set of questions to review with the patient;
  • Language on cath lab governance and the responsibilities of a cath lab director. Techniques are provided on how CCLs can improve function through effective governance and management strategies;
  • Information on cost consideration. Specific strategies CCLs can employ to provide the highest value of care are outlined;
  • Information on radial access. There is recent support for radial access procedures (procedures done through the wrist), which were not covered in the 2012 paper. Best practices on when radial access is appropriate and considerations CCLs should take is included;
  • New evidence on medications. Recent data includes medications brought to market after the 2012 paper and when to use certain drugs and dosage amounts;
  • Recommendations on maintaining appropriate industry relationships, for example:
    • Industry’s role in individual CCLs should be consistent with policies set by the hospital and/or director;
    • Industry should not have “hands-on” equipment in the CCL, except for defined educational purposes or device preparation; and
    • Industry should always provide information and advice that is in the best interest of the patient, regardless of other considerations.
  • Techniques for enhancing patient satisfaction in the CCL including pre-, intra-, and post-procedure recommendations for improving patient satisfaction.

The paper, which cross-references other SCAI reports and documents, clearly reflects the direction in which the profession of interventional cardiology is heading.

“SCAI is a valuable organization for cardiologists to join as it lends them a voice and the opportunity to impact and influence the future of interventional cardiology,” said Sunil V. Rao, M.D., FSCAI, chair of SCAI’s Quality Improvement Committee, associate professor of medicine at the Duke University Medical Center and section chief of cardiology at Durham VA Medical Center.

“The guidelines reflect SCAI’s commitment and continued efforts to improve quality of care and the patient experience,” said SCAI President James C. Blankenship, M.D., MHCM, FSCAI, MACC, practicing interventional cardiologist at Geisinger Medical Center in Danville, Pa., and director of the Geisinger cardiology department and catheterization laboratories.

For more information:

Related Content

Tryton Side Branch Stent Recognized With Premier Technology Breakthrough Award
News | Stents Bifurcation| September 21, 2017
September 21, 2017 — Cardinal Health and Tryton Medical Inc.
DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Overlay Init